Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinase

7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinase

US Patent 8354416 · Granted Jan 15, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of screening for high-affinity, isoform-selective TGFβ1 inhibitors2025
Heterocyclic GLP-1 agonists2025
Isoform-selective TGFB1 inhibitors and use thereof2024
Ether linked triazoles as NRF2 activators2024
Compounds2024
Heterocyclic amides useful as protein modulators2024
Heterocyclic GLP-1 agonists2024
Heterocyclic GLP-1 agonists2024
Heterocyclic GLP-1 agonists2024
Heterocyclic GLP-1 agonists2022
Isoform-selective TGFβ1 inhibitors and use thereof2021
Bisaryl heterocycles as NRF2 activators2021